Olupot-Olupot P
Epidemiological dynamics of influenza B virus across multiple seasons in Kenya and Uganda inferred from sequence data, 2010-2021.Nyarango BK, Owuor DC, Isoe E, Mutunga M, Cheruiyot R, Katama EN, Makori T, Lambisia A, Nyiro J, Githinji G, Kiguli S, Olupot-Olupot P, Maitland K, Agoti CN
BMC Infect Dis, (2025). 25:1080
Single low dose primaquine to block the transmission of Plasmodium falciparum-proposed stand-alone and ACT-adapted regimens.Taylor WRJ, Olupot-Olupot P, Onyamboko MA, Chimjinda N, Taya C, Pouplin JNN, Williams TN, Maitland K, Fanello CA, Day NPJ, Tarning J, White NJ, Mukaka M
BMC Med, (2025). 23:397
Early weaning from oxygen therapy in African children with severe pneumonia.Maitland K, Giallongo E, Hamaluba M, Alaroker F, Opoka RO, Tagoola A, Nalwanga D, Nabawanuka E, Okiror W, Nakuya M, Aromut D, Williams TN, Thomas K, Harrison DA, Mouncey P, Bush A, Fraser JF, Rowan K, Olupot-Olupot P, Kiguli S
BMC Med, (2025). 23:366
Intravenous Rehydration for Severe Acute Malnutrition with Gastroenteritis.Maitland K, Ouattara SM, Sainna H, Chara A, Ogundipe OF, Sunyoto T, Hamaluba M, Olupot-Olupot P, Alaroker F, Connon R, Saidou Maguina A, Okiror W, Amorut D, Mwajombo E, Oguda E, Mogaka C, Langendorf C, Dewez JE, Ciglenecki I, Gibb DM, Coldiron ME, Petrucci R, George EC
N Engl J Med, (2025). :
Comparing HemoCue® and Quantitative Buffy Coat® and Coulter Counter-measured haemoglobin concentrations in African children with acute uncomplicated malaria: a Bland-Altman analysis.Ayuen DS, Olupot-Olupot P, Muhindo R, Onyamboko MA, Ajayi S, Chimjinda N, Taya C, Uyoga S, Williams TN, Maitland K, Fanello C, Day NPJ, Taylor WR, Mukaka M
Malar J, (2025). 24:77
Comparing HemoCue® and Quantitative Buffy Coat® and Coulter Counter-measured haemoglobin concentrations in African children with acute uncomplicated malaria: a Bland-Altman analysis.Ayuen DS, Olupot-Olupot P, Muhindo R, Onyamboko MA, Ajayi S, Chimjinda N, Taya C, Uyoga S, Williams TN, Maitland K, Fanello C, Day NPJ, Taylor WR, Mukaka M
Malar J, (2025). 24:77
Catastrophic expenditure associated with childhood hospitalisation for acute illness in Kenya and Uganda: a cross-sectional study.Jemutai J, Njuguna RG, Laurence YV, Murunga S, Ogwang C, Mwaringa S, Mwalekwa L, Timbwa M, Paasi G, Olupot-Olupot P, Juma M, Thitiri J, Ngao N, Singa B, Mukisa J, Mupere E, Lancioni C, Sukhtankar P, Tickell KD, Fakhar Uddin M, Molyneux S, Walson JL, Vassall A, Berkley J
BMJ Public Health, (2025). 3:e001173
Effect of nutritional supplementation with lipid-based therapeutic food on body composition of non-severely malnourished African children aged 6-59 months hospitalized with severe pneumonia.Nalwanga D, Musiime V, Kiguli S, Olupot-Olupot P, Alaroker F, Opoka R, Tagoola A, Mnjala H, Mogaka C, Nabawanuka E, Giallongo E, Karamagi C, Briend A, Maitland K
J Trop Pediatr, (2025). 71:
Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trial.Connon R, Olupot-Olupot P, Pistorius AMA, Okiror W, Ssenyondo T, Muhindo R, Uyoga S, Mpoya A, Williams TN, Gibb DM, Walker AS, Ter Heine R, George EC, Maitland K
BMC Med, (2024). 22:516
Is fat mass a better predictor of 6-month survival than muscle mass among African children aged 6-59 months with severe pneumonia?.Nalwanga D, Musiime V, Kiguli S, Olupot-Olupot P, Alaroker F, Opoka R, Tagoola A, Mnjalla H, Mogaka C, Nabawanuka E, Giallongo E, Karamagi C, Briend A, Maitland K
BMC Nutr, (2024). 10:130
Nutritional supplementation in children with severe pneumonia in Uganda and Kenya (COAST-Nutrition): a phase 2 randomised controlled trial.Kiguli S, Olupot-Olupot P, Hamaluba M, Giallongo E, Thomas K, Alaroker F, Opoka RO, Tagoola A, Oyella S, Nalwanga D, Nabawanuka E, Okiror W, Nakuya M, Amorut D, Muhindo R, Mpoya A, Mnjalla H, Oguda E, Williams TN, Harrison DA, Rowan K, Briend A, Maitland K
EClinicalMedicine, (2024). 72:102640
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.Aygun B, Lane A, Smart LR, Santos B, Tshilolo L, Williams TN, Olupot-Olupot P, Stuber SE, Tomlinson G, Latham T, Ware RE
Lancet Haematol, (2024). S2352-3026:00078-4
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.Aygun B, Lane A, Smart LR, Santos B, Tshilolo L, Williams TN, Olupot-Olupot P, Stuber SE, Tomlinson G, Latham T, Ware RE
Lancet Haematol, (2024). 11:e425-e435
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.Power-Hays A, Tomlinson GA, Tshilolo L, Santos B, Williams TN, Olupot-Olupot P, Smart LR, Aygun B, Lane A, Stuber SE, Latham T, Ware RE
Am J Hematol, (2024). 99:625-632
Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo.Onyamboko MA, Olupot-Olupot P, Were W, Namayanja C, Onyas P, Titin H, Baseke J, Muhindo R, Kayembe DK, Ndjowo PO, Basara BB, Okalebo CB, Williams TN, Uyoga S, Taya C, Bamisaiye A, Fanello C, Maitland K, Day NPJ, Taylor WRJ, Mukaka M
BMC Med, (2023). 21:397
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria.Mukaka M, Onyamboko MA, Olupot-Olupot P, Peerawaranun P, Suwannasin K, Pagornrat W, Kouhathong J, Madmanee W, Were W, Namayanja C, Onyas P, Titin H, Baseke J, Muhindo R, Kayembe DK, Ndjowo PO, Basara BB, Bongo GS, Okalebo CB, Abongo G, Uyoga S, Williams TN, Taya C, Dhorda M, Dondorp AM, Waithira N, Imwong M, Maitland K, Fanello C, Day NPJ, Tarning J, White NJ, Taylor WRJ
EBioMedicine, (2023). 96:104805
Cardiovascular abnormalities in chest radiographs of children with pneumonia, Uganda.Nabawanuka E, Ameda F, Erem G, Bugeza S, Opoka RO, Kiguli S, Amorut D, Aloroker F, Olupot-Olupot P, Mnjalla H, Mpoya A, Maitland K
Bull World Health Organ, (2023). 101:202-210
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.Taylor WR, Olupot-Olupot P, Onyamboko MA, Peerawaranun P, Weere W, Namayanja C, Onyas P, Titin H, Baseke J, Muhindo R, Kayembe DK, Ndjowo PO, Basara BB, Bongo GS, Okalebo CB, Abongo G, Uyoga S, Williams TN, Taya C, Dhorda M, Tarning J, Dondorp AM, Waithira N, Fanello C, Maitland K, Mukaka M, Day NJP
Lancet Infect Dis, (2022). 23:471-483
Hydroxyurea is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.Olupot-Olupot P, Tomlinson G, Williams TN, Tshilolo LMM, Santos B, Smart LR, McElhinney K, Howard TA, Aygun B, Stuber SE, Lane A, Latham T, Ware RE
Blood, (2022). 141:1402-1410
High false discovery rate of the Architect anti-HCV screening test in blood donors in Uganda and evaluation of an algorithm for confirmatory testing.Lucey O, Acana S, Olupot-Olupot P, Muhindo R, Ayikobua R, Uyoga S, Kyeyune-Byabazaire D, Cooke G, Maitland K
Vox Sang, (2022). 117:1360-1367
